Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24858487)

1.

Timing of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors.

Kaku S, Ushioda N, Ishii H, Murakami T, Takahashi K, Nakai Y, Shimoya K, Nakamura T.

Oncol Rep. 2014 Jul;32(1):16-22. doi: 10.3892/or.2014.3202. Epub 2014 May 20.

2.

Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.

Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1370-7. Epub 2006 Sep 18.

PMID:
16979836
3.

Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.

Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L, Yang Z.

Clin Transl Oncol. 2014 Jun;16(6):567-72. doi: 10.1007/s12094-013-1120-3. Epub 2013 Oct 9.

PMID:
24105048
4.

Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).

Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K; Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group.

Int J Gynecol Cancer. 2012 Oct;22(8):1420-6.

PMID:
22932262
5.

Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial.

Mitsuhashi A, Uno T, Usui H, Nishikimi K, Yamamoto N, Watanabe M, Tate S, Hirashiki K, Kato K, Yamazawa K, Shozu M.

Int J Gynecol Cancer. 2013 Oct;23(8):1453-8. doi: 10.1097/IGC.0b013e3182559bda.

PMID:
23266648
6.

Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.

Oike T, Ohno T, Noda SE, Sato H, Tamaki T, Kiyohara H, Ando K, Nakano T.

J Radiat Res. 2013 May;54(3):474-8. doi: 10.1093/jrr/rrs121. Epub 2012 Dec 14.

7.
9.

[Chemoradiotherapy in cancers of the uterine cervix].

Maingon P, Coucke P, Haie-M├ęder C, Barillot I.

Cancer Radiother. 1998 Dec;2(6):718-22. Review. French.

PMID:
9922779
10.

Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.

Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.

Anticancer Res. 1999 Sep-Oct;19(5C):4463-7.

PMID:
10650793
11.

Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Vile RG, Uster PS, Peters AM, Stewart JS.

Clin Cancer Res. 2000 Dec;6(12):4939-49.

12.

[Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone].

Nakahara S, Yoshino K, Fujii T, Uemura H, Suzuki M, Nishiyama K, Inohara H.

Nihon Jibiinkoka Gakkai Kaiho. 2012 Oct;115(10):902-9. Japanese.

PMID:
23214048
13.

Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers.

Baykara M, Buyukberber S, Ozturk B, Coskun U, Kaplan MA, Unsal DK, Dane F, Demirci U, Bora H, Benekli M; Anatolian Society of Medical Oncology.

Tumori. 2013 Jul-Aug;99(4):469-73. doi: 10.1700/1361.15096.

PMID:
24326834
14.

Outcomes and toxicities for the treatment of stage IVB cervical cancer.

Hwang JH, Lim MC, Seo SS, Kang S, Park SY, Kim JY.

Arch Gynecol Obstet. 2012 Jun;285(6):1685-93. doi: 10.1007/s00404-011-2173-6. Epub 2011 Dec 16.

PMID:
22173823
15.

Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.

Jakubowicz J, Blecharz P, Skotnicki P, Reinfuss M, Walasek T, Luczynska E.

Eur J Gynaecol Oncol. 2014;35(4):393-9.

PMID:
25118480
16.

Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.

Takeshita S, Kita T, Motoike Y, Umezawa K, Sugisaki S, Matsumoto S, Matsumoto Y, Ryo E, Ayabe T.

J Obstet Gynaecol Res. 2010 Oct;36(5):1009-14. doi: 10.1111/j.1447-0756.2010.01275.x. Epub 2010 Aug 17.

PMID:
20722988
17.

[Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].

Li XF, Li YH, Gao YN, Li CL, Yue HZ, Xu G, Li DM, Su X.

Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):763-7. Chinese.

PMID:
24406134
19.

Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.

Ryu SY, Lee WM, Kim K, Park SI, Kim BJ, Kim MH, Choi SC, Cho CK, Nam BH, Lee ED.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e577-81. doi: 10.1016/j.ijrobp.2011.05.002. Epub 2011 Aug 11.

PMID:
21840137
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk